Sopheon, the InnovationOps software company, announced that Sasol will use Accolade® to automate its innovation processes and portfolio management. Sopheon will make it possible for Sasol Chemicals in Germany, which has responsibility for research and development (R&D) on a global basis, to utilize a best practices-based implementation and execute a long-term vision for digitalization of processes and ideation.
Sasol Germany, headquartered in Hamburg, manufactures high-quality chemical products and has production facilities in Brunsbüttel and Marl. The company is part of the South African Sasol Group, an integrated chemical and energy group that manufactures and markets world-class products in 22 countries. Sasol fulfills its purpose of “innovating for a better world" by producing a broad range of innovative and sustainable specialty chemicals and chemical feedstocks for a variety of applications and industries.
“With global operations, it was mission-critical to harmonize and automate our R&D processes,” said Dr. Klaus Kwetkat of Sasol Germany GmbH. “Sopheon has vast experience from more than 400 projects, references for digitalizing product development processes, and out-of-the-box best practices that are included in their software. We look forward to improving our product development capabilities and innovation performance with Sopheon.”
Sopheon’s innovation software offerings help organizations in five critical areas: discovery, idea management, product management, project management and innovation management. Sopheon enables a perfect combination of creativity and structure that allows companies to respond to market needs in real time.
“Sasol is known for working closely with customers to continuously develop its product portfolio and adapt production processes to new findings and market requirements,” said Greg Coticchia, chief executive officer of Sopheon. “Accolade is an ideal fit for helping Sasol reach its goals. It will foster visibility and accountability while ensuring that Sasol's innovation management always aligns with the company’s strategic objectives.
